Achieving Quality 24-h Blood Pressure Control with Candesartan Cilexetil

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Hypertension Management

Background:

• Optimal blood pressure control necessitates consistent 24-hour reduction.
• Antihypertensive medications require good tolerability and once-daily dosing for compliance.
• The renin-angiotensin system plays a crucial role in blood pressure regulation.

Purpose of the Study:

• To evaluate the 24-hour antihypertensive efficacy of candesartan cilexetil.
• To compare the sustained blood pressure lowering effects of candesartan cilexetil and losartan.
• To assess the trough-to-peak ratio as a measure of antihypertensive persistence.

Main Methods:

• Administration of candesartan cilexetil (8 and 16 mg) and losartan (50 and 100 mg).
• Measurement of trough-to-peak ratio to assess efficacy persistence.
• Ambulatory blood pressure monitoring (0-36 hours) and clinic measurements (48 hours).

Main Results:

• Candesartan cilexetil demonstrated a trough-to-peak ratio close to the ideal 1.0.
• Losartan (50 mg) showed a trough-to-peak ratio of 0.7.
• Candesartan cilexetil (16 mg) exhibited significantly greater antihypertensive effect than losartan (100 mg) up to 48 hours post-dosing.

Conclusions:

• Candesartan cilexetil provides smooth, sustained 24-hour blood pressure control.
• Its long-lasting action and favorable trough-to-peak ratio suggest improved patient compliance.
• Candesartan cilexetil offers enhanced cardiovascular protection, even with occasional missed doses.